CytomX shares fall on portfolio reshuffle (CTMX:NASDAQ)


Cut unnecessary expenses.

Andrii Yalanskyi

Shares of CytomX Therapeutics (NASDAQ:CTMX) fell on Tuesday after the cancer drug developer announced a roughly 40% reduction in its workforce as part of a portfolio reorganization drive aimed at cost savings.

Citing plans to allocate resources to the maximum



Source link

  • Related Posts

    Meet the influencer with Musk’s ear on Germany’s far right By Reuters

    By Thomas Escritt BERLIN (Reuters) – In his public journey to embrace the far-right Alternative for Germany (AfD) in Germany, Elon Musk has consistently boosted the online content of a…

    Dubai developer DAMAC signs $1 billion deal with blockchain platform MANTRA

    DUBAI (Reuters) – MANTRA, a blockchain platform focused on real-world assets (RWA), has signed a deal with Dubai developer DAMAC Group to tokenize assets in the Middle East worth at…

    Leave a Reply

    Your email address will not be published. Required fields are marked *